Recombinant Protein Production News and Research

RSS
ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

BAC, Octapharma enter licence agreement for G-CSF CaptureSelect custom affinity ligand

BAC, Octapharma enter licence agreement for G-CSF CaptureSelect custom affinity ligand

Study identifies options for restoring knee cartilage lubrication to prevent OA

Study identifies options for restoring knee cartilage lubrication to prevent OA

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

HZI researchers develop new method to produce insulin for treatment of diabetes

HZI researchers develop new method to produce insulin for treatment of diabetes

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

KTH Royal Institute of Technology Stockholm, BioSilta Oy collaborate to optimise protein screening

Protein Potential receives Phase II SBIR Grant to develop vaccine for prevention of P. vivax infections

Protein Potential receives Phase II SBIR Grant to develop vaccine for prevention of P. vivax infections

EUREKA project develops unique range of antibodies

EUREKA project develops unique range of antibodies

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

Fraunhofer USA CMB receives $4.395M award from DARPA to develop H1N1 influenza vaccine

Halozyme Therapeutics reports net loss of $12.7M for fourth-quarter of 2009

Halozyme Therapeutics reports net loss of $12.7M for fourth-quarter of 2009

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Study shows CEL-2000 vaccine blocks RA progression in mice

Study shows CEL-2000 vaccine blocks RA progression in mice

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

EPO to grant patent notice to BioMimetic Therapeutics

EPO to grant patent notice to BioMimetic Therapeutics

Normal protein can be converted into prion that causes fatal brain diseases in humans

Normal protein can be converted into prion that causes fatal brain diseases in humans

Repligen announces five-year supply agreement for recombinant Protein A with GE Healthcare Bio-Sciences

Repligen announces five-year supply agreement for recombinant Protein A with GE Healthcare Bio-Sciences

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Laureate Pharma, Selexis SA collaborate to provide streamlined access to complementary contract services

Laureate Pharma, Selexis SA collaborate to provide streamlined access to complementary contract services